Jul 1, 2026 04:05PM
Jun 30, 2026 07:15AM
Jun 30, 2026 07:15AM
Jun 24, 2026 07:30AM
Jun 24, 2026 07:30AM
Jun 3, 2026 04:05PM
Jun 3, 2026 04:05PM ADC Therapeutics Announces Results From LOTIS-5 Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
May 4, 2026 07:30AM
May 1, 2026 04:57AM
May 1, 2026 04:05AM
Apr 27, 2026 07:30AM
Apr 1, 2026 04:05PM
Mar 10, 2026 07:30AM
Mar 10, 2026 07:30AM ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update
Mar 3, 2026 07:15AM
Mar 2, 2026 04:05PM
Feb 24, 2026 07:15AM
Feb 23, 2026 07:15AM
Feb 23, 2026 07:15AM
Feb 2, 2026 04:05PM
Jan 8, 2026 04:05PM ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates
Jan 8, 2026 07:15AM
Jan 2, 2026 04:05PM
Dec 3, 2025 07:30AM
Dec 3, 2025 07:30AM
Dec 2, 2025 04:05PM
Dec 1, 2025 04:05PM
Nov 10, 2025 07:30AM ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update
Nov 3, 2025 07:15AM
Oct 27, 2025 07:15AM
Oct 13, 2025 07:30AM
Oct 13, 2025 07:30AM
Oct 1, 2025 04:05PM
Oct 1, 2025 06:54AM
Sep 2, 2025 04:05PM ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Aug 27, 2025 07:15AM
Aug 12, 2025 07:30AM
Aug 5, 2025 04:05PM
Aug 1, 2025 04:05PM
Jul 1, 2025 04:05PM
Jun 20, 2025 09:50AM
Jun 16, 2025 07:15AM ADC Therapeutics SA (ADCT) Announces Updated Data from ZYNLONTA Investigator-Initiated Trial R/R Marginal Zone Lymphoma
Jun 16, 2025 07:15AM
Jun 12, 2025 06:46AM
Jun 12, 2025 06:45AM
Jun 12, 2025 06:30AM
Jun 12, 2025 06:30AM
Jun 2, 2025 04:05PM
May 15, 2025 07:15AM ADC Therapeutics to Present at Upcoming Investor Conferences
May 14, 2025 08:00AM

326,432 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All